ABOUT THE EVENT
Date: Wednesday, September 17, 2025 8am–6:10pm PDT
Event Location: San Francisco , California
hubXchange is pleased to present the Advanced Therapies Xchange – San Francisco 2025, a high-level, invitation-only event tailored for senior executives and scientists. This unique forum explores the most pressing scientific and strategic challenges across the therapeutic and development pipeline for oligonucleotides and peptides.
Focus Tracks
Next Gen Vector Engineering & Delivery
Gene Therapy CMC & Process Development
Cell Therapy Development
Cell Therapy Manufacturing
🔹 Why Attend?
✅ Join thought-provoking roundtables led by leading researchers and developers
✅ Discover emerging tools, technologies, and delivery systems in nucleic acid and peptide therapeutics
✅ Network in pre-booked 1:1 meetings with key stakeholders
✅ Explore cutting-edge poster and spotlight presentations
✅ Collaborate on next-gen delivery, safety, and scalability solutions
🔹 Agenda Highlights
Keynote Presentation
Accelerating the Journey from Development to Commercialization – Xumei Wan, Minaris Advanced TherapiesExpert-Led Roundtables
Personalised cell therapy engineering – Senti Bio
Scalable autologous platforms – Bayer
AAV design & alternative vectors – Avista Therapeutics
Regulatory CMC frameworks – AstraZeneca
Expanding cell therapy into non-oncology – SK pharmteco
Automation and consumables integration – Invetech
Pivotal trial readiness strategies – Senti Bio
Potency assays for γδ T cell therapies – Adicet Bio
Minimizing AAV empty capsids – Ultragenyx
Spotlight Presentation
Genomic safety & analytical characterization in gene therapy – ProtaGene
Poster Presentations
Closed modular CGT manufacturing – Excellos/Terumo BCT
Rapid CAR-T production using Cocoon® – Lonza
AAV manufacturing cost models – Cytiva
Aphaeresis starting material for γδ T cells – Excellos
Networking & Partnering
Multiple 1:1 meeting sessions
Networking lunch and evening drinks reception
